Literature DB >> 25789411

Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F.

Kathryn J Quigley1, Catherine J Reynolds, Amelie Goudet, Eleanor J Raynsford, Ruhena Sergeant, Andrew Quigley, Stefan Worgall, Diana Bilton, Robert Wilson, Michael R Loebinger, Bernard Maillere, Daniel M Altmann, Rosemary J Boyton.   

Abstract

RATIONALE: Pseudomonas aeruginosa (PA) is an environmental pathogen that commonly infects individuals with cystic fibrosis (CF) and non-CF bronchiectasis, impacting morbidity and mortality. To understand the pathobiology of interactions between the bacterium and host adaptive immunity and to inform rational vaccine design, it is important to understand the adaptive immune correlates of disease.
OBJECTIVES: To characterize T-cell immunity to the PA antigen outer membrane porin F (OprF) by analyzing immunodominant epitopes in relation to infection status.
METHODS: Patients with non-CF bronchiectasis were stratified by frequency of PA isolation. T-cell IFN-γ immunity to OprF and its immunodominant epitopes was characterized. Patterns of human leukocyte antigen (HLA) restriction of immunodominant epitopes were defined using HLA class II transgenic mice. Immunity was characterized with respect to cytokine and chemokine secretion, antibody response, and T-cell activation transcripts.
MEASUREMENTS AND MAIN RESULTS: Patients were stratified according to whether PA was never, sometimes (<50%), or frequently (≥50%) isolated from sputum. Patients with frequent PA sputum-positive isolates were more likely to be infected by mucoid PA, and they showed a narrow T-cell epitope response and a relative reduction in Th1 polarizing transcription factors but enhanced immunity with respect to antibody production, innate cytokines, and chemokines.
CONCLUSIONS: We have defined the immunodominant, HLA-restricted T-cell epitopes of OprF. Our observation that chronic infection is associated with a response of narrowed specificity, despite strong innate and antibody immunity, may help to explain susceptibility in these individuals and pave the way for better vaccine design to achieve protective immunity.

Entities:  

Keywords:  Pseudomonas; T lymphocyte; adaptive immunity; bronchiectasis; epitopes

Mesh:

Substances:

Year:  2015        PMID: 25789411      PMCID: PMC4476516          DOI: 10.1164/rccm.201411-1995OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  62 in total

Review 1.  British Thoracic Society guideline for non-CF bronchiectasis.

Authors:  M C Pasteur; D Bilton; A T Hill
Journal:  Thorax       Date:  2010-07       Impact factor: 9.139

Review 2.  Pseudomonas aeruginosa: host defence in lung diseases.

Authors:  Bryan J Williams; Joanne Dehnbostel; Timothy S Blackwell
Journal:  Respirology       Date:  2010-08-16       Impact factor: 6.424

3.  Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia.

Authors:  Weihui Wu; Jin Huang; Biyan Duan; David C Traficante; Haeyeon Hong; Martina Risech; Stephen Lory; Gregory P Priebe
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

4.  Full virulence of Pseudomonas aeruginosa requires OprF.

Authors:  Laurène Fito-Boncompte; Annelise Chapalain; Emeline Bouffartigues; Hichem Chaker; Olivier Lesouhaitier; Gwendoline Gicquel; Alexis Bazire; Amar Madi; Nathalie Connil; Wilfried Véron; Laure Taupin; Bertrand Toussaint; Pierre Cornelis; Qing Wei; Koki Shioya; Eric Déziel; Marc G J Feuilloley; Nicole Orange; Alain Dufour; Sylvie Chevalier
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

5.  CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.

Authors:  Karen K Chu; Patcharaporn Tippayawat; Nicola J Walker; Sarah V Harding; Helen S Atkins; Bernard Maillere; Gregory J Bancroft; Ganjana Lertmemongkolchai; Daniel M Altmann
Journal:  Eur J Immunol       Date:  2010-12-03       Impact factor: 5.532

6.  The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation.

Authors:  Scott M Gordon; Julie Chaix; Levi J Rupp; Junmin Wu; Sharline Madera; Joseph C Sun; Tullia Lindsten; Steven L Reiner
Journal:  Immunity       Date:  2012-01-18       Impact factor: 31.745

7.  Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.

Authors:  Anja Krause; Wen Zhu Whu; Yaqin Xu; Ju Joh; Ronald G Crystal; Stefan Worgall
Journal:  Vaccine       Date:  2011-01-06       Impact factor: 3.641

8.  Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

Authors:  Dan H Barouch; Kara L O'Brien; Nathaniel L Simmons; Sharon L King; Peter Abbink; Lori F Maxfield; Ying-Hua Sun; Annalena La Porte; Ambryice M Riggs; Diana M Lynch; Sarah L Clark; Katherine Backus; James R Perry; Michael S Seaman; Angela Carville; Keith G Mansfield; James J Szinger; Will Fischer; Mark Muldoon; Bette Korber
Journal:  Nat Med       Date:  2010-02-21       Impact factor: 53.440

9.  Interactions between polymorphonuclear leukocytes and Pseudomonas aeruginosa biofilms on silicone implants in vivo.

Authors:  Maria van Gennip; Louise Dahl Christensen; Morten Alhede; Klaus Qvortrup; Peter Østrup Jensen; Niels Høiby; Michael Givskov; Thomas Bjarnsholt
Journal:  Infect Immun       Date:  2012-05-14       Impact factor: 3.441

10.  The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells.

Authors:  Nick Powell; Alan W Walker; Emilie Stolarczyk; James B Canavan; M Refik Gökmen; Ellen Marks; Ian Jackson; Ahmed Hashim; Michael A Curtis; Richard G Jenner; Jane K Howard; Julian Parkhill; Thomas T MacDonald; Graham M Lord
Journal:  Immunity       Date:  2012-10-11       Impact factor: 31.745

View more
  12 in total

1.  Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease.

Authors:  Fathia G Jaat; Sajidah F Hasan; Audrey Perry; Sharon Cookson; Santosh Murali; John D Perry; Clare V Lanyon; Anthony De Soyza; Stephen M Todryk
Journal:  Respir Res       Date:  2018-05-30

2.  Infection with Burkholderia pseudomallei - immune correlates of survival in acute melioidosis.

Authors:  Susanna J Dunachie; Kemajittra Jenjaroen; Catherine J Reynolds; Kathryn J Quigley; Ruhena Sergeant; Manutsanun Sumonwiriya; Panjaporn Chaichana; Suchintana Chumseng; Pitchayanant Ariyaprasert; Patricia Lassaux; Louise Gourlay; Charuporn Promwong; Prapit Teparrukkul; Direk Limmathurotsakul; Nicholas P J Day; Daniel M Altmann; Rosemary J Boyton
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

3.  Bioluminescent Reporting of In Vivo IFN-γ Immune Responses during Infection and Autoimmunity.

Authors:  Catherine J Reynolds; Deborah L W Chong; Yihan Li; S Lucas Black; Amy Cutler; Zoe Webster; Jiten Manji; Daniel M Altmann; Rosemary J Boyton
Journal:  J Immunol       Date:  2019-02-27       Impact factor: 5.422

4.  Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.

Authors:  Catherine J Reynolds; Corinna Pade; Joseph M Gibbons; Áine McKnight; Daniel M Altmann; Rosemary Boyton; David K Butler; Ashley D Otter; Katia Menacho; Marianna Fontana; Angelique Smit; Jane E Sackville-West; Teresa Cutino-Moguel; Mala K Maini; Benjamin Chain; Mahdad Noursadeghi; Tim Brooks; Amanda Semper; Charlotte Manisty; Thomas A Treibel; James C Moon; Ana M Valdes
Journal:  Science       Date:  2021-04-30       Impact factor: 63.714

5.  BIITE: A Tool to Determine HLA Class II Epitopes from T Cell ELISpot Data.

Authors:  Lies Boelen; Patrick K O'Neill; Kathryn J Quigley; Catherine J Reynolds; Bernard Maillere; John H Robinson; Ganjana Lertmemongkolchai; Daniel M Altmann; Rosemary J Boyton; Becca Asquith
Journal:  PLoS Comput Biol       Date:  2016-03-08       Impact factor: 4.475

6.  T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses.

Authors:  C J Reynolds; O M Suleyman; A M Ortega-Prieto; J K Skelton; P Bonnesoeur; A Blohm; V Carregaro; J S Silva; E A James; B Maillère; M Dorner; R J Boyton; D M Altmann
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

Review 7.  The Role of the Immune Response in the Pathogenesis of Bronchiectasis.

Authors:  Paul T King
Journal:  Biomed Res Int       Date:  2018-03-18       Impact factor: 3.411

Review 8.  Gender differences in bronchiectasis: a real issue?

Authors:  Celine Vidaillac; Valerie F L Yong; Tavleen K Jaggi; Min-Min Soh; Sanjay H Chotirmall
Journal:  Breathe (Sheff)       Date:  2018-06

9.  Clinical Features of Patients with Bronchiectasis with Comorbid Chronic Obstructive Pulmonary Disease in China.

Authors:  Chenli Xie; Yongtao Wen; Yiju Zhao; Sufen Zeng; Qingling Guo; Qiuting Liang; Lichong Chen; Yuanbin Liu; Fuman Qiu; Lei Yang; Jiachun Lu
Journal:  Med Sci Monit       Date:  2019-09-10

10.  Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia.

Authors:  Michaela Gregorova; Daniel Morse; Tarcisio Brignoli; Laura Rivino; Ruth C Massey; Joseph Steventon; Fergus Hamilton; Mahableshwar Albur; David Arnold; Matthew Thomas; Alice Halliday; Holly Baum; Christopher Rice; Matthew B Avison; Andrew D Davidson; Marianna Santopaolo; Elizabeth Oliver; Anu Goenka; Adam Finn; Linda Wooldridge; Borko Amulic; Rosemary J Boyton; Daniel M Altmann; David K Butler; Claire McMurray; Joanna Stockton; Sam Nicholls; Charles Cooper; Nicholas Loman; Michael J Cox
Journal:  Elife       Date:  2020-12-17       Impact factor: 8.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.